Healthcare -
Biotechnology - NASDAQ - US
$ 43.33
-0.161 %
$ 4 B
Market Cap
-6.82
P/E
RARE - PRE-TAX INCOME
Pre-tax Income RARE - Ultragenyx Pharmaceutical Inc.
-608 M
LAST VALUE
-15.90%
2 YEAR CAGR
-25.29%
5 YEAR CAGR
-33.02%
10 YEAR CAGR